Market Place
Sourcing Support
Freya Pharma Solutions Announces Advice from the FDA on its US Devp of Lybrido
09 May 2023 //
PR NEWSWIRE
Freya Pharma Solutions appoints Christa van Kan as Director Clinical Operations
08 Mar 2023 //
PR NEWSWIRE
Freya`s innovative compound Lybrido received at European Society
22 Feb 2023 //
PR NEWSWIRE
Freya Pharma Solutions extends its Scientific Advisory Board with experts
10 Feb 2023 //
PR NEWSWIRE
Freya Pharma Solutions appoints Nicole Hijnen as President of the Board
02 Feb 2023 //
PR NEWSWIRE
Freya: ALETTA Pivotal Trial Well Received at ISSM/SMSNA Scientific Meeting
04 Nov 2022 //
PRNEWSWIRE
Female sexual interest drug reaches tipping point with Phase III plans
10 Oct 2022 //
PHARMACEUTICAL-TECHNOLOGY
Freya Receives EMA Scientific Advice on its upcoming Phase 3 Clinical Trial
28 Sep 2022 //
PRNEWSWIRE
Freya Pharma Solutions Announced Further Strengthening of its IP Position
25 Aug 2022 //
PRNEWSWIRE
Freya Pharma Applied for EMA Advice on PIII Trial to Confirm Efficacy of Lybrido
29 Jun 2022 //
PRNEWSWIRE
Freya Pharma establishes Scientific Advisory Board with leading European experts
25 May 2022 //
PRNEWSWIRE
Freya Pharma Appoints Dr. Jan van der Mooren as CMO
12 Apr 2022 //
PRNEWSWIRE
Freya Pharma Solutions secures US$8.5M for phase 3 trial with Lybrido
29 Mar 2022 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.